Stem Cells – Medicine of the future
In the last decade, the use of Stem Cells has emerged as a highly promising therapeutic strategy for diseases that currently lack treatment options. One example is osteoarthritis (OA), affecting over 630 million people worldwide. OA is a chronic debilitating and painful joint disease, characterised by cartilage degradation and loss of chondrocyte function. Based on its proprietary marker technology, Xintela is bringing a novel Stem Cell-based therapy to the patients that has distinct advantages over the current standard of care. This disruptive solution has game-changing potential in a market void of a cure for OA.